{"title":"Uncovering the possible link between dietary advanced glycation end products and mortality risk: A systematic review and meta-analysis","authors":"Hamid Ahmadirad , Hossein Farhadnejad , Mostafa Norouzzadeh , Mitra Kazemi Jahromi , Ebrahim Mokhtari , Morteza Omrani , Farshad Teymoori , Reza Sadeghi , Parvin Mirmiran , Maryam Bagherian","doi":"10.1016/j.canep.2025.102807","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Recently, observational studies have focused on dietary advanced glycation end products (dAGEs) as predictive risk factors for chronic diseases and their related mortality. The current systematic review and meta-analysis aimed to synthesize the available evidence and quantify the possible association of dAGEs and risk of all-cause or cause-specific mortality.</div></div><div><h3>Methods</h3><div>A comprehensive and systematic search was conducted in online literature databases, including PubMed, Scopus and Web of Science until January 2025 without any language limitation. The hazard ratio (HR) with 95 % confidence interval (CI) for the included studies were extracted and converted into log HR. Also, we used a random-effects model with inverse variance weighting method to compute the pooled effect size.</div></div><div><h3>Results</h3><div>Six eligible studies (including 18 reports) were included in the current meta-analysis. 111,543 participants, aged 45.6–79 years old, participated in these observational studies, and the duration of follow-up varied from 3.8 to 16 years. According to the pooled results of our analysis, no significant association was observed between dAGEs and its components with the risk of all-cause mortality (HR=1.02; 95 %CI=0.92, 1.13; I<sup>2</sup>= 73.2 %), cancer mortality (HR=1.00; 95 %CI=0.88, 1.13; I<sup>2</sup>= 41.0 %) and CVDs mortality (HR=1.16; 95 %CI=0.86, 1.55; I<sup>2</sup>=86.1 %). Sex, target population, dAGEs components, region, dAGEs assessment method, and dietary data collection methods were the sources of heterogeneity.</div></div><div><h3>Conclusions</h3><div>In conclusion, our study suggested that there was no significant association between dAGEs intake and all-cause or cause-specific mortality.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"96 ","pages":"Article 102807"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877782125000670","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Recently, observational studies have focused on dietary advanced glycation end products (dAGEs) as predictive risk factors for chronic diseases and their related mortality. The current systematic review and meta-analysis aimed to synthesize the available evidence and quantify the possible association of dAGEs and risk of all-cause or cause-specific mortality.
Methods
A comprehensive and systematic search was conducted in online literature databases, including PubMed, Scopus and Web of Science until January 2025 without any language limitation. The hazard ratio (HR) with 95 % confidence interval (CI) for the included studies were extracted and converted into log HR. Also, we used a random-effects model with inverse variance weighting method to compute the pooled effect size.
Results
Six eligible studies (including 18 reports) were included in the current meta-analysis. 111,543 participants, aged 45.6–79 years old, participated in these observational studies, and the duration of follow-up varied from 3.8 to 16 years. According to the pooled results of our analysis, no significant association was observed between dAGEs and its components with the risk of all-cause mortality (HR=1.02; 95 %CI=0.92, 1.13; I2= 73.2 %), cancer mortality (HR=1.00; 95 %CI=0.88, 1.13; I2= 41.0 %) and CVDs mortality (HR=1.16; 95 %CI=0.86, 1.55; I2=86.1 %). Sex, target population, dAGEs components, region, dAGEs assessment method, and dietary data collection methods were the sources of heterogeneity.
Conclusions
In conclusion, our study suggested that there was no significant association between dAGEs intake and all-cause or cause-specific mortality.
期刊介绍:
Cancer Epidemiology is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including:
• Descriptive epidemiology
• Studies of risk factors for disease initiation, development and prognosis
• Screening and early detection
• Prevention and control
• Methodological issues
The journal publishes original research articles (full length and short reports), systematic reviews and meta-analyses, editorials, commentaries and letters to the editor commenting on previously published research.